Tecogen (TGEN)
(Delayed Data from OTC)
$0.89 USD
0.00 (0.29%)
Updated Sep 19, 2024 03:28 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Tecogen Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 25 | 25 | 24 | 28 | 33 |
Cost Of Goods | 15 | 14 | 13 | 17 | 21 |
Gross Profit | 10 | 11 | 12 | 11 | 12 |
Selling & Adminstrative & Depr. & Amort Expenses | 15 | 13 | 13 | 17 | 17 |
Income After Depreciation & Amortization | -4 | -2 | -1 | -6 | -5 |
Non-Operating Income | 0 | 0 | 5 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -4 | -2 | 4 | -6 | -5 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -5 | -2 | 4 | -6 | -5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -5 | -2 | 4 | -6 | -5 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -4 | -2 | -1 | -3 | -1 |
Depreciation & Amortization (Cash Flow) | 1 | 0 | 0 | 3 | 4 |
Income After Depreciation & Amortization | -4 | -2 | -1 | -6 | -5 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 24.85 | 24.85 | 25.12 | 24.85 | 24.84 |
Diluted EPS Before Non-Recurring Items | -0.19 | -0.10 | 0.15 | -0.16 | -0.07 |
Diluted Net EPS (GAAP) | -0.19 | -0.10 | 0.15 | -0.25 | -0.19 |
Fiscal Year end for Tecogen Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 4.73 | 6.19 | 5.90 | 7.11 | 6.75 |
Cost Of Goods | 2.65 | 3.61 | 3.55 | 4.19 | 3.91 |
Gross Profit | 2.08 | 2.58 | 2.35 | 2.93 | 2.83 |
SG&A, R&D, and Dept/Amort Expenses | 3.56 | 3.62 | 4.16 | 3.29 | 3.62 |
Income After SG&A, R&D, and Dept/Amort Expenses | -1.48 | -1.04 | -1.81 | -0.36 | -0.79 |
Non-Operating Income | -0.02 | 0.00 | -0.02 | -0.07 | 0.02 |
Interest Expense | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 |
Pretax Income | -1.51 | -1.07 | -1.83 | -0.45 | -0.77 |
Income Taxes | 0.00 | 0.02 | 0.00 | 0.00 | 0.01 |
Minority Interest | 0.03 | 0.02 | 0.02 | 0.03 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -1.51 | -1.09 | -1.83 | -0.45 | -0.78 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -1.54 | -1.10 | -1.85 | -0.48 | -0.78 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 24.85 | 24.85 | 24.85 | 24.85 | 24.85 |
Diluted EPS Before Non-Recurring Items | -0.06 | -0.04 | -0.07 | -0.02 | -0.03 |
Diluted Net EPS (GAAP) | -0.06 | -0.04 | -0.08 | -0.02 | -0.03 |